US Corporate Distress Financial Stress SEC Filings — January 05, 2026

06-01-2026

Marblegate Capital Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003211, Size: 7 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction value, parties involved, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory filing signaling a potentially significant agreement and financial obligation.

06-01-2026

Geron Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003388), reporting under Item 1.01 entry into a material definitive agreement. No details on the agreement's terms, parties, value, or strategic context are disclosed in the provided filing summary. Sector is not specified.

06-01-2026

IGC Pharma, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001185185-26-000032, size: 305 KB) reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. Sector not specified. No details on the agreement, transaction value, or other specifics provided.

06-01-2026

Compass Diversified Holdings filed a Form 8-K on January 6, 2026 (AccNo: 0001345126-26-000005, Size: 238 KB), reporting a delisting-related event under Item 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing) and Item 9.01 (Financial Statements and Exhibits). No specific details on the delisting reasons, transaction values, financial impacts, or other quantitative metrics are disclosed. Sector is not specified.

06-01-2026

AMERICAN REBEL HOLDINGS INC filed a Form 8-K on January 06, 2026 (AccNo: 0001493152-26-000461, Size: 586 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, or counterparties disclosed in the provided information. Core event involves a material agreement creating financial obligations and equity sales.

06-01-2026

Trinity Industries Inc filed a Form 8-K on January 6, 2026 (AccNo: 0000099780-26-000006, Size: 702 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, disclosures, transaction value, or financial impacts provided in the summary. All quantitative data, named entities beyond the filer, and event specifics are NOT_DISCLOSED.

06-01-2026

Sunrun Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001193125-26-003449, Size: 1 MB), disclosing under Item 1.01 entry into a Material Definitive Agreement and under Item 2.03 creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement. Item 9.01 includes Financial Statements and Exhibits. No transaction details, dollar values, or other quantitative data are provided in the filing summary.

06-01-2026

KALA BIO, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001829126-26-000055), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This is a multi-item filing with no specific transaction details, dollar values, or numerical data disclosed in the provided summary. Sector is not specified.

06-01-2026

Cyclerion Therapeutics, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003509, Size: 8 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with sector not specified. No quantitative data, transaction details, or other specifics disclosed in the provided information.

06-01-2026

Aspire Biopharma Holdings, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000518, Size: 447 KB), reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing with no specific details on the agreement, transaction value, share count, or parties provided in the summary. All financial metrics, dollar values, and quantitative impacts are NOT_DISCLOSED.

06-01-2026

eHealth, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001333493-26-000003), reporting multiple events including entry into (Item 1.01) and termination of (Item 1.02) material definitive agreements, creation of a direct financial obligation (Item 2.03), material modifications to rights of security holders (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, or numerical data disclosed. Core events suggest significant corporate restructuring, but all key metrics are NOT_DISCLOSED.

06-01-2026

LifeMD, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000525, Size: 2 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, or other numerical data disclosed in the provided information. Sector is not specified.

06-01-2026

Harvard Apparatus Regenerative Technology, Inc. filed an 8-K on January 06, 2026 (AccNo: 0001437749-26-000452, Size: 341 KB), reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing from the US SEC source. No specific transaction details, amounts, or financial metrics are disclosed in the provided summary.

06-01-2026

Company filed 8-K on 2026-01-06 (AccNo: 0001628280-26-000873, Size: 73 MB) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item Material Event filing from the US SEC with no specific transaction details, dollar values, parties, or financial metrics disclosed in the provided summary. Sector not specified.

06-01-2026

SolarMax Technology, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001640334-26-000032, Size: 1 MB), reporting Items 1.01 (Entry into a Material Definitive Agreement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing classified as a Material Event, but specific details on the agreement, transaction terms, or disclosures are NOT_DISCLOSED. No quantitative financial data or named entities beyond the filer are provided.

06-01-2026

Immunic, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193805-26-000011, Size: 188 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. This discloses a delisting event from the US market. No additional details on reasons, financial impacts, or transaction values are provided.

06-01-2026

Electronic Arts Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0000712515-26-000002, Size: 145 KB), reporting under Item 1.02 the termination of a material definitive agreement, under Item 2.04 triggering events that accelerate or increase a direct financial obligation or off-balance sheet arrangement, and under Item 8.01 other events. No specific details on the core event, transaction value, parties involved, financial impacts, or timelines are disclosed in the provided filing summary. This is a multi-item filing likely mandatory given the material nature.

06-01-2026

Dror Ortho-Design, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001784, size 778 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties, or financial impacts are disclosed in the provided information. Sector is not specified.

06-01-2026

PMGC Holdings Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001213900-26-001782, Size: 3 MB) as a multi-item disclosure covering Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, transaction values, financial metrics, named entities beyond the filer, or quantitative impacts are disclosed in the provided filing summary. Sector is not specified.

06-01-2026

Estrella Immunopharma, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001777, Size: 1 MB), reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, transaction terms, parties, values, or financial impacts provided in the summary. Sector is not specified.

06-01-2026

Barinthus Biotherapeutics plc. filed a Form 8-K on January 6, 2026 (AccNo: 0001828185-26-000004, Size: 190 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No details on delisting reasons, transaction values, financial impacts, or related entities are disclosed. Sector is not specified.

06-01-2026

Tradeweb Markets Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001758730-26-000008, Size: 165 KB), reporting under Item 1.01 entry into a material definitive agreement. No details on the agreement's nature, parties, transaction value, or financial terms are disclosed in the provided filing summary. All specific quantitative data and named entities beyond the filer are NOT_DISCLOSED.

06-01-2026

BayFirst Financial Corp. filed an 8-K on 2026-01-06 (AccNo: 0001649739-26-000003, Size: 183 KB) reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, transaction value, parties, or exhibits provided in the available summary. Sector not specified.

06-01-2026

T-Mobile US, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004596, Size: 1 MB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 2.03 Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement, and Item 9.01 Financial Statements and Exhibits. No details on the specific agreement, transaction value, parties involved, or financial terms are disclosed in the provided summary. This is a multi-item mandatory filing likely related to a financing or debt arrangement.

06-01-2026

PLUG POWER INC filed an 8-K on January 6, 2026 (AccNo: 0001104659-26-001336, size 314 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, counterparties, or financial impacts are disclosed in the provided filing summary. Sector not specified.

06-01-2026

Mobileye Global Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001340), disclosing Entry into a Material Definitive Agreement (Item 1.01), Unregistered Sales of Equity Securities (Item 3.02), and Financial Statements and Exhibits (Item 9.01). This is a multi-item mandatory filing with no specific details on the agreement, securities sale, transaction value, or financial impacts provided in the available information. Sector not specified.

06-01-2026

Oncotelic Therapeutics, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001493152-26-000613, Size: 208 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific transaction details, dollar values, or quantitative data disclosed in the provided summary. Sector not specified.

06-01-2026

Middleby Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004740, size 160 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, counterparties, transaction value, or financial impacts are disclosed in the provided summary. Sector not specified.

06-01-2026

STAAR Surgical Co filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004699, size 141 KB), disclosing under Item 1.02 the termination of a material definitive agreement and under Item 5.07 the submission of matters to a vote of security holders. No details on the agreement, vote outcomes, dollar values, or financial impacts are provided in the summary. Sector not specified.

06-01-2026

Instil Bio, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001789769-26-000004, Size: 146 KB) disclosing under Item 1.02 the termination of a material definitive agreement. Sector not specified. No details on the agreement counterparties, value, financial impacts, or strategic rationale provided.

06-01-2026

OneStream, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004772, Size: 1 MB), reporting multiple items: Item 1.01 (Entry into a Material Definitive Agreement), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details, transaction values, or financial metrics disclosed in the provided information. Sector not specified.

06-01-2026

CareView Communications Inc filed a Form 8-K on 2026-01-06 (AccNo: 0001437749-26-000653, Size: 316 KB) reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. No details on transaction parties, value, terms, or financial metrics are disclosed in the provided summary. Sector not specified.

06-01-2026

Murphy Oil Corp filed a Form 8-K on January 6, 2026 (AccNo: 0000950103-26-000187, size 12 MB), reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing from the US SEC source, but specific details on transactions, financial metrics, dollar values, or impacts are NOT_DISCLOSED. Sector is not specified.

06-01-2026

Safe & Green Development Corp filed a Form 8-K on January 06, 2026 (AccNo: 0001213900-26-001868, Size: 483 KB), reporting entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03. Item 9.01 includes Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties, or financial terms are disclosed in the provided information.